þ | No fee required. |
o
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
(2)
|
Aggregate
number of securities to which transaction
applies:
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant
to
Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is
calculated and state how it was
determined):
|
(4)
|
Proposed
maximum aggregate value of
transaction:
|
(5)
|
Total
fee paid:
|
o
|
Fee
paid previously with preliminary
materials.
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule
0-11(a)(2) and identify the filing for which the offsetting fee was
paid
previously. Identify the previous filing by registration statement
number,
or the Form or Schedule and the date of its filing.
|
(1)
|
Amount
Previously Paid:
|
(2)
|
Form,
Schedule or Registration Statement
No.:
|
(3)
|
Filing
Party:
|
(4)
|
Date
Filed:
|
Very
truly yours,
Leslie
J. Christon
President
and Chief Executive Officer
|
(1)
|
To
elect six directors to serve for the ensuing year;
and
|
(2)
|
To
transact such other business as may properly come before the meeting,
or
any adjournment or postponement of the
meeting.
|
Warren
R. Nelson
Secretary
|
Page
|
|
|
|
ABOUT
THE MEETING
|
1
|
INFORMATION
ABOUT OWNERSHIP OF OUR COMMON STOCK
|
4
|
PROPOSAL
NO. 1—ELECTION OF DIRECTORS
|
8
|
EXECUTIVE
COMPENSATION
|
13
|
STOCK
OPTION AND COMPENSATION COMMITTEE REPORT
|
16
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
|
27
|
AUDIT
COMMITTEE REPORT
|
29
|
RELATIONSHIP
WITH OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
30
|
OTHER
MATTERS
|
31
|
ANNEX
A - SHELLS SEAFOOD RESTAURANTS AUDIT COMMITTEE CHARTER
|
Beneficial
Ownership
|
Percent
of
|
||||||
Name
and Address of Beneficial Owner
|
Amount
|
Class
|
|||||
Philip
R. Chapman
|
|||||||
400
Madison Avenue, Suite 7C
|
|||||||
New
York, NY 10017 (1)
|
4,601,682
|
19.45
|
%
|
||||
Leslie
J. Christon (2)
|
1,620,064
|
6.44
|
%
|
||||
Michael
R. Golding
|
|||||||
230
Pleasant Valley Road
|
|||||||
Morganville,
NJ 07751 (3)
|
90,000
|
*
|
|||||
Gary
L. Herman
|
|||||||
Galloway
Capital Management, LLC
|
|||||||
720
Fifth Avenue, 10th
Floor
|
|||||||
New
York, NY 10019 (4)
|
934,989
|
3.96
|
%
|
||||
Christopher
D. Illick
|
|||||||
735
Iris Lane
|
|||||||
Vero
Beach, FL 32963 (5)
|
121,500
|
*
|
|||||
Jay
A. Wolf
|
|||||||
c/o
Trinad Capital, L.P.
|
|||||||
2121
Avenue of the Stars, Suite 2550
|
|||||||
Los
Angeles, CA 90067 (6)
|
4,344,315
|
17.89
|
%
|
||||
Guy
C. Kathman (7)
|
216,667
|
*
|
|||||
Warren
R. Nelson (8)
|
424,918
|
1.78
|
%
|
Beneficial
Ownership
|
|
Percent
|
|||||
Name
and Address of Beneficial Owner
|
Amount
|
|
of
Class
|
||||
Christopher
R. Ward, Sr. (9)
|
100,001
|
*
|
|||||
Frederick
R. Adler
|
|||||||
1520
South Ocean Blvd.
|
|||||||
Palm
Beach, FL 33480 (10)
|
3,783,858
|
15.13
|
%
|
||||
James
R. Adler
|
|||||||
400
Madison Avenue, Suite 7C
|
|||||||
New
York, NY 10017 (11)
|
4,455,682
|
18.93
|
%
|
||||
Robert
Ellin
|
|||||||
c/o
Trinad Capital, L.P.
|
|||||||
2121
Avenue of the Stars, Suite 2550
|
|||||||
Los
Angeles, CA 90067 (12)
|
4,264,315
|
17.62
|
%
|
||||
Bruce
Galloway
|
|||||||
Galloway
Capital Management LLC
|
|||||||
720
Fifth Avenue, 10th
Floor
|
|||||||
New
York, NY 10019 (13)
|
2,957,364
|
12.49
|
%
|
||||
Banyon
Investment, LLC
|
|||||||
400
Madison Avenue, Suite 7C
|
|||||||
New
York, NY 10017
|
4,454,015
|
18.92
|
%
|
||||
Lagunitas
Partners, LP
|
|||||||
50
Osgood Place, Penthouse
|
|||||||
San
Francisco, CA 94133 (14)
|
2,600,010
|
10.65
|
%
|
||||
Pequot
Capital Management, Inc.
|
|||||||
500
Nyala Farm Road
|
|||||||
Westport,
CT 06880 (15)
|
1,333,330
|
5.36
|
%
|
|
Beneficial
Ownership
|
Percent of |
|||||
Name
and Address of Beneficial Owner
|
Amount
|
Class
|
|||||
Trinad
Advisors GP, LLC
|
|||||||
2121
Avenue of the Stars, Suite 2550
|
|||||||
Los
Angeles, CA 90067 (16)
|
4,264,315
|
17.62
|
%
|
||||
Trinad
Capital Master Fund, Ltd.
|
|||||||
2121
Avenue of the Stars, Suite 2550
|
|||||||
Los
Angeles, CA 90067 (16)
|
4,264,315
|
17.62
|
%
|
||||
All
directors and executive officers as a group (9 persons)
(17)
|
12,454,136
|
46.94
|
%
|
*
|
less
than 1%
|
(1)
|
Includes
(i) 4,454,015 shares of common stock owned by Banyon Investment,
LLC, and
(ii) 116,000 shares of common stock which may be acquired through
the
exercise of options held by Mr. Chapman. Mr. Chapman and Mr. James
Adler
are co-managing members of Banyon Investment, LLC and share voting
and
investment powers.
|
(2)
|
Includes
1,605,064 shares of common stock which may be acquired through the
exercise of options. Does not include options to purchase 653,845
shares
of common stock which are not exercisable within 60 days of August
15,
2007.
|
(3)
|
Consists
of 90,000 shares of common stock which may be acquired through the
exercise of options.
|
(4)
|
Includes
(i) 562,800 shares of common stock owned by Strategic Turnaround
Equity
Partners, L.P. (Cayman) (“STEP”), an investment fund; (ii) 193,751 shares
of common stock owned by Galloway Capital Management, LLC; (iii)
80,000
shares of common stock which may be acquired through the exercise
of
options; and (iv) 4,688 shares of common stock owned by a trust for
the
benefit of Mr. Herman’s children. Mr. Herman
is a managing member of Galloway Capital Management, LLC, a managing
member of the general partner of STEP, and the trustee of the
aforementioned trust.
|
(5)
|
Consists
of 121,500 shares of common stock which may be acquired through the
exercise of options. Does not include options to purchase 22,500
shares of
common stock which are not exercisable within 60 days of August 15,
2007.
|
(6)
|
Consists
of (i) 3,521,548 shares of common stock owned by Trinad Capital Master
Fund, Ltd.; (ii) 22,270 shares of Series B Preferred Stock convertible
into 445,400 shares of common stock, owned by Trinad Capital Master
Fund,
Ltd.; (iii) warrants to purchase 222,700 shares of common stock owned
by
Trinad Capital Master Fund, Ltd.; (iv) 80,000 shares of common stock
which
may be acquired through the exercise of options and (v) 74,667 shares
of
common stock owned by Trinad Capital, LP. Mr. Wolf is a managing
director
of Trinad Management, LLC which is the manager of Trinad Capital
Master
Fund, Ltd.
|
(7)
|
Consists
of 216,667 shares of common stock which may be acquired through the
exercise of options. Does not include options to purchase 158,333
shares
of common stock which are not exercisable within 60 days of August
15,
2007.
|
(8)
|
Includes
359,650 shares of common stock which may be acquired through the
exercise
of options. Does not include options to purchase 242,326 shares of
common
stock which are not exercisable within 60 days of August 15,
2007.
|
(9)
|
Consists
of 100,001 shares of common stock which may be acquired through the
exercise of options. Does not include options to purchase 104,999
shares
of common stock with are not exercisable within 60 days of August
15,
2007.
|
(10)
|
Includes
(i) 48,833 shares of Series B Preferred Stock convertible into 976,660
shares of common stock and (ii) warrants to purchase 488,330 shares
of
common stock. Does not include 4,454,015 shares of common stock owned
by
Banyon Investment, LLC. Mr. Adler’s son, James Adler, is a co-managing
member of Banyon Investment, LLC.
|
(11)
|
Includes
4,454,015 shares of common stock owned by Banyon Investment, LLC.
Mr.
James Adler and Mr. Chapman
are co-managing members of Banyon Investment, LLC and share voting
and
investment powers. Does not include any share held by Mr. Frederick
Adler,
the father of Mr. James
Adler.
|
(12)
|
Consists
of (i) 3,521,548 shares of common stock owned by Trinad Capital Master
Fund, Ltd.; (ii) 22,270 shares of Series B Preferred Stock convertible
into 445,400 shares of common stock, owned by Trinad Capital Master
Fund,
Ltd.; (iii) warrants to purchase 222,700 shares of common stock owned
by
Trinad Capital Master Fund, Ltd.; and (iv) 74,667 shares of common
stock
owned by Trinad Capital, LP. Mr. Ellin is a managing director of
Trinad
Management, LLC which is the manager of Trinad Capital Master Fund,
Ltd.
|
(13)
|
Consists
of (i) 562,800 shares of common stock owned by Strategic Turnaround
Equity
Partners, L.P. (Cayman) (“STEP”), an investment fund of which Mr. Galloway
is a managing member of Galloway Capital Management, LLC, STEP’s general
partner; (ii) 193,751 shares of common stock owned by Galloway Capital
Management, LLC of which 50% is to the benefit of Mr. Galloway; (iii)
1,955,793 shares of common stock owned by the Bruce Galloway, IRA
R/O;
(iv) warrants to purchase 143,420 shares of common stock owned by
the
Bruce Galloway, IRA R/O; (v) 24,100 shares of common stock owned
by Rexon
Galloway Capital Growth, LLC for which Mr. Galloway has the right
to vote
and dispose; and (vi) 77,500 shares of common stock owned by Mr.
Galloway’s children for which Mr. Galloway has the right to vote and
dispose.
|
(14)
|
Consists
of (i) 1,733,340 shares of common stock and (ii) a warrant to purchase
866,670 shares of common stock.
|
(15)
|
Consists
of warrants to purchase 1,333,330 shares beneficially owned by Pequot
Scout Fund, LP and Pequot Mariner Offshore Fund, LP. Pequot Capital
Management, Inc. is the investment adviser of Pequot Scout Fund,
LP and
Pequot Mariner Offshore Fund, LP.
|
(16)
|
Consists
of (i) 3,521,548 shares of common stock owned by Trinad Capital Master
Fund, Ltd.; (ii) 22,270 shares of Series B Preferred Stock convertible
into 445,400 shares of common stock owned by Trinad Capital Master
Fund,
Ltd.; (iii) warrants to purchase 222,700 shares of common stock owned
by
Trinad Capital Master Fund, Ltd.; and (iv) 74,667 shares of common
stock
owned by Trinad Capital, LP. Trinad Advisors GP, LLC is the general
partner of Trinad Capital Master Fund,
Ltd.
|
(17)
|
Includes
(i) 9,017,154 shares of common stock, and (ii) 2,755,548 shares of
common
stock which may be acquired through the exercise of options. Does
not
include options to purchase an aggregate of 1,195,337 shares of common
stock which are not exercisable within 60 days of August 15,
2007.
|
Director
|
|||
Director
|
Age
|
Since
|
Principal
Occupation During the Past Five Years
|
Philip
R. Chapman
|
45
|
1997
|
Since
1993, Mr. Chapman has been President of Adler &
|
Company,
a corporation which provides administrative
|
|||
services
for financial and venture capital investing, including
|
|||
certain
entities controlled by Frederick R. Adler, a greater
than
|
|||
10%
stockholder. Mr. Chapman is a director of Regeneration
|
|||
Technologies,
Inc., a company which produces allografts for
|
|||
surgical
use, and of various private companies. He is also a
|
|||
managing
partner of Alpha Beta Capital Management LLC, a
|
|||
private
hedge fund. Mr. Chapman is the son-in-law of
|
|||
Frederick
R. Adler. Mr. Chapman has served as Chairman of
|
|||
our
company since April 2002.
|
|||
Leslie
J. Christon
|
53
|
2004
|
Mrs.
Christon has served as our President and Chief
Executive
|
Officer
since joining our company in July 2003. From 2002 to
|
|||
2003,
Mrs. Christon was self-employed as a management
|
|||
consultant
in the restaurant industry. From 2000 to 2002, Mrs.
|
|||
Christon
was employed by Sutton Place Gourmet, Inc. as its
|
|||
President
and Chief Operating Officer. From 1996 to 2000,
|
|||
Mrs.
Christon was employed by Brinker International, On the
|
|||
Border
Restaurants, as its President.
|
|||
Michael
R. Golding
|
74
|
2002
|
Dr.
Golding has been a professor of surgery at the State
|
University
of New York Health Science Center in Brooklyn,
|
|||
New
York since 1963, where he is currently an Emeritus
|
|||
Clinical
Professor of Surgery. From 1977 to 1989, Dr.
|
|||
Golding
served as Director of Surgery at Lutheran Medical
|
|||
Center
in Brooklyn, New York. From 1984 to 1989, Dr.
|
|||
Golding
was President of the Tri-Boro Association
of
|
Director
|
|||
Director
|
Age
|
Since
|
Principal
Occupation During the Past Five Years
|
Directors
of Surgery. Dr. Golding is a Fellow of the American
|
|||
College
of Surgeons, a Fellow of the American College of
|
|||
Chest
Physicians, and a Fellow of the American College of
|
|||
Angelology.
Dr. Golding is a Member of the Board of
|
|||
Directors
of the United Hospital Fund. Dr. Golding also serves
|
|||
on
the boards of numerous professional entities and
private
|
|||
companies.
|
|||
Gary
L. Herman
|
43
|
2004
|
Mr.
Herman has been a member of Galloway Capital
|
Management,
LLC, an affiliate of a greater than 10%
|
|||
stockholder,
since 2002. Mr. Herman has been the Chairman
|
|||
and
Secretary of Digital Creative Development Corporation,
|
|||
an
investment holding company, since 2001. He has been the
|
|||
Secretary
and a member of the Board of Directors of
|
|||
DataMetrics
Corporation, a military defense company, since
|
|||
2000,
and Chairman since 2005. From 1997 to 2002, Mr.
|
|||
Herman
was an Associate Managing Director of Burnham
|
|||
Securities,
Inc.
|
|||
Christopher
D. Illick
|
68
|
1998
|
Mr.
Illick was the President of iQ Venture Partners, Inc.,
an
|
investment
bank, from 2001 until March 2007 and was
|
|||
formerly
a General Partner of Illick Brothers, a real estate and
|
|||
management
concern, since 1965. From 1997 to 2001, Mr.
|
|||
Illick
was a senior officer of the investment bank of Brean
|
|||
Murray
& Co., Inc. Mr. Illick is currently a private
investor.
|
|||
Jay
A. Wolf
|
34
|
2004
|
Since
2004, Mr. Wolf has served as a Managing Director of
|
Trinad
Capital, L.P., an activist hedge fund. From 1999 to
|
|||
2003,
Mr. Wolf served as Vice President of Corporate
|
|||
Development
for Wolf Group Integrated Communications
|
|||
Ltd.,
a marketing communications firm, where he was
|
|||
responsible
for the company’s acquisition program. From
|
|||
1996
to 1999, Mr. Wolf was employed by Canadian Corporate
|
|||
Funding,
Ltd., a Toronto-based merchant bank in the senior
|
|||
debt
department and, subsequently by Trillium Growth
|
|||
Capital,
the firm’s venture capital fund. Mr. Wolf currently
|
|||
sits
on the Board of ProLink Holdings Corp., a public
|
|||
company
providing electronic GPS services to the golf
|
|||
industry,
and US Wireless Data, Inc., a public development
|
|||
stage
company.
|
•
|
compensation
should encourage increased stockholder
value;
|
•
|
compensation
programs should reflect and promote our values and reward individuals
for
outstanding contributions towards business goals;
and
|
•
|
compensation
programs should enable us to attract and retain highly qualified
professionals.
|
•
|
Reviewed
and publicly available executive compensation information for comparable
executive officers within the restaurant industry peer
group;
|
•
|
determined
a mix of base salary and bonus opportunity, along with an equity
position
to align our executive officers’ compensation with our
performance;
|
•
|
assessed
our executive officers’ performance;
and
|
•
|
assessed
our financial and business results compared to other companies within
the
restaurant industry and our financial performance relative to our
past
performance and financial goals.
|
NON-EQUITY
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
INCENTIVE
|
|
|
|
|
|
||||||
|
|
|
|
|
|
OPTION
|
|
PLAN
|
|
ALL
|
|
||||||||
NAME
AND PRINCIPAL POSITION
|
FISCAL YEAR |
|
SALARY (1) |
|
AWARDS(2)
|
|
COMPENSATION(1)(3)
|
|
OTHER COMPENSATION |
TOTAL
|
|||||||||
Leslie
J. Christon
|
2006
|
$
|
300,000
|
—
|
$
|
21,155
|
$
|
12,530
|
$
|
333,685
|
|||||||||
Chief
Executive Officer and
|
|||||||||||||||||||
President
|
|||||||||||||||||||
(Principal
Executive Officer) (4)
|
|||||||||||||||||||
Warren
R. Nelson
|
2006
|
166,904
|
$
|
11,596
|
9,484
|
868
|
188,852
|
||||||||||||
Executive
Vice President of
|
|||||||||||||||||||
Finance,
|
|||||||||||||||||||
Chief
Financial Officer, Secretary
|
|||||||||||||||||||
and
Treasurer
|
|||||||||||||||||||
(Principal
Financial Officer) (5)
|
|||||||||||||||||||
Guy
C. Kathman
|
2006
|
144,634
|
3,517
|
8,348
|
516
|
157,015
|
|||||||||||||
Vice
President of Operations (6)
|
|||||||||||||||||||
Christopher
R. Ward, Sr.
|
2006
|
127,927
|
3,227
|
7,539
|
-
|
138,693
|
|||||||||||||
Vice
President of Purchasing
|
|||||||||||||||||||
(1)
|
All
of the salaries and non-equity incentive plan compensation for the
named
executive officers in fiscal 2006 were paid in
cash.
|
(2)
|
Option
awards consist of compensation cost recognized in our financial statements
with respect to awards granted in previous fiscal years and the subject
fiscal year. Option awards are expensed on a straight-line basis
over the
vesting period of the award. The option awards are valued at fair
value
using the Black- Scholes option pricing model. Effective January
1, 2006,
we adopted the fair value based method of accounting for stock-based
employee compensation as required by SFAS No. 123R, “Share-Based Payment.”
The fair value based method requires us to expense all stock-based
employee compensation. See Note 1 and Note 14 to our audited financial
statements for the 2006 fiscal year, contained in Part I Item 8 “Financial
Statements”, of our Annual Report on Form 10-K for the year ended December
31, 2006, for the methodology used and assumptions made in the valuation
of our options.
|
(3)
|
All
non-equity incentive plan compensation earned by our named executive
officers for the 2006 fiscal year under the 2006 Management Compensation
Plan was paid during such period as disclosed in the column above.
See
Compensation Discussion and Analysis for a discussion of the 2006
Management Compensation Plan in our Annual Report on Form 10-K for
the
year ended December 31, 2006.
|
(4)
|
Other
compensation for Mrs. Christon includes an automobile allowance of
$1,000
per month and life insurance premiums paid by Shells of $530. Effective
as
of July 1, 2007, Mrs. Christon’s salary was reduced to $275,000 per annum
and her automobile allowance was increased to $1,200 per
month.
|
(5)
|
Other
compensation for Mr. Nelson consists of life insurance premiums paid
by
Shells of $868, in the aggregate, for policy years covering 2005
and
2006.
|
(6)
|
Other
compensation for Mr. Kathman consists of life insurance premiums
paid by
Shells of $516.
|
NUMBER
OF SECURITIES
|
|
|
|
||||||
|
UNDERLYING
UNEXERCISED
|
|
|
|
|||||
|
OPTIONS
|
|
OPTION
|
|
|||||
|
(NUMBER
OF SHARES)(#)
|
|
EXERCISE
|
OPTION
|
|||||
|
|
UNEXERCISABLE
|
|
PRICE
|
EXPIRATION
|
||||
NAME
|
EXERCISABLE
|
(1)
|
|
PER
SHARE
|
DATE
|
||||
Leslie
J. Christon
|
297,374
|
-
|
$ |
0.62
|
7/6/2013
|
||||
150,000
|
300,000
|
(2)
|
1.10
|
3/21/2015
|
|||||
150,000
|
300,000
|
(3)
|
0.76
|
6/12/2013
|
|||||
353,844
|
707,691
|
(4)
|
0.85
|
7/1/2012
|
|||||
Warren
R. Nelson
|
5,000
|
-
|
5.13
|
1/10/2009
|
|||||
10,000
|
-
|
2.00
|
2/6/2010
|
||||||
20,000
|
-
|
0.45
|
4/18/2011
|
||||||
152,771
|
5,213
|
(5)
|
0.42
|
2/28/2012
|
|||||
41,666
|
83,334
|
(6)
|
1.10
|
3/21/2015
|
|||||
41,666
|
83,334
|
(7)
|
0.76
|
6/13/2012
|
|||||
Guy
C. Kathman
|
50,000
|
-
|
0.64
|
9/23/2013
|
|||||
41,666
|
83,334
|
(6)
|
1.10
|
3/21/2015
|
|||||
41,666
|
83,334
|
(7)
|
0.76
|
6/13/2012
|
|||||
Christopher
R. Ward, Sr.
|
26,667
|
13,333
|
(8)
|
0.71
|
9/7/2014
|
||||
15,000
|
30,000
|
(9)
|
1.10
|
3/21/2015
|
|||||
15,000
|
30,000
|
(10)
|
0.76
|
6/13/2012
|
(1)
|
See
Termination of Employment and Change in Control Arrangements, following
this table, for additional information regarding
vesting.
|
(2)
|
These
options vested and became exercisable as to 150,000 shares on March
21,
2007 and will vest and become exercisable as to an additional 150,000
shares on March 21, 2008.
|
(3)
|
These
options vested and became exercisable as to 150,000 shares on June
13,
2007 and will vest and become exercisable as to an additional 150,000
shares on June 13, 2008.
|
(4)
|
These
options vested and became exercisable as to 353,845 shares on July
1, 2007
and will vest and become exercisable as to an additional 353,846
shares on
July 1, 2008.
|
(5)
|
These
became fully vested and exercisable on February 28,
2007.
|
(6)
|
These
options vested and became exercisable as to 41,667 shares on March
21,
2007 and will vest and become exercisable as to an additional 41,666
shares on March 21, 2008.
|
(7)
|
These
options vested and became exercisable as to 41,667 shares on June
13, 2007
and will vest and become exercisable as to an additional 41,666 shares
on
June 13, 2008.
|
(8)
|
These
options vested and became exercisable on September 7,
2007.
|
(9)
|
These
options vested and became exercisable as to 15,000 shares on March
21,
2007 and will vest and become exercisable as to an additional 15,000
shares on March 21, 2008.
|
(10)
|
These
options vested and became exercisable as to 15,000 shares on June
13, 2007
and will vest and become exercisable as to an additional 15,000 shares
on
June 13, 2008.
|
|
|
|
||||||||||||||||||||||||||||
|
STOCK
|
STOCK
|
STOCK
|
|||||||||||||||||||||||||||
OPTIONS
|
OPTIONS |
OPTIONS
|
||||||||||||||||||||||||||||
SEVERANCE
|
(#
OF
|
MEDICAL
|
SEVERANCE
|
(#
OF
|
|
MEDICAL
|
SEVERANCE |
(#
OF
|
|
MEDICAL | ||||||||||||||||||||
PAYMENT
|
|
SHARES)
|
BENEFITS
|
PAYMENT
|
SHARES)
|
BENEFITS
|
PAYMENT
|
SHARES)
|
|
BENEFITS
|
||||||||||||||||||||
Leslie
J. Christon
|
$
|
150,000
|
(1
|
)
|
951,218
|
$
|
5,965
|
(2
|
)
|
N/A
|
951,218
|
N/A
|
$
|
150,000
|
1,307,691
|
(3
|
)
|
$
|
5,965
|
(2
|
)
|
|||||||||
Warren
R. Nelson
|
167,000
|
271,103
|
N/A
|
N/A
|
271,103
|
N/A
|
167,000
|
171,881
|
(3
|
)
|
11,930
|
(4
|
)
|
|||||||||||||||||
Guy
C. Kathman
|
N/A
|
133,332
|
N/A
|
N/A
|
133,332
|
N/A
|
108,150
|
166,668
|
(3
|
)
|
8,947
|
(4
|
)
|
|||||||||||||||||
Christopher
R. Ward, Sr.
|
N/A
|
56,667
|
N/A
|
N/A
|
56,667
|
N/A
|
96,000
|
73,333
|
(3
|
)
|
8,947
|
(4
|
)
|
(1)
|
Mrs.
Christon’s severance payment is subject to deduction in the event she
becomes employed elsewhere within such six month
period.
|
(2)
|
Mrs.
Christon will receive payment of COBRA continuation health coverage
premiums for the six-month period from the date of termination; provided
that she is not employed by another entity for such
period.
|
(3)
|
Amount
represents unvested options as of December 31, 2006 including
out-of-the-money stock options. If the executive officer is not offered
a
comparable position with Shells, or if , provided executive is not
terminated without cause within six months of the change in control
or
executive terminates his employment with Shells as a result of being
required to relocate outside the Tampa, Florida Market, then in all
such
cases, the option immediately becomes vested and exercisable in full.
If
the executive officer is offered a comparable position with Shells,
the
option immediately becomes vested and exercisable with respect to
one-half
of the shares of common stock for which the option is not vested
and
exercisable and if the executive officer accepts such comparable
position
through the first anniversary of the change in control, the option,
to the
extent not already vested and exercisable, will become vested and
exercisable on such first
anniversary
|
(4)
|
Mr.
Nelson will continue to receive health coverage for a one-year period
following termination and Messrs. Kathman and Ward will receive such
premiums for a nine-month period following termination; provided
that that
such executive does not become employed by another entity during
such
period.
|
Director
Compensation
|
||||
For
the 2006 fiscal year, we paid our non-employee directors fees as
follows:
|
||||
DIRECTOR'S
|
||||
DESCRIPTION
|
FEE
|
|||
Annual
retainer paid in quarterly installments
|
$
|
10,000
|
||
Additional
annual fee paid to Audit Committee Chair (paid in quarterly
installments)
|
$
|
10,000
|
||
Annual
stock option grant (# of shares)
|
20,000
|
|||
Additional
annual stock option grant awarded to Audit Committee Chair (# of
shares)
|
30,000
|
FEES
|
|
OPTION
|
|
|
|
|||||
|
|
EARNED
OR
|
|
AWARDS
|
||||||
NAME
|
PAID
IN CASH(1)
|
|
(in
$’s)(2)(3)
|
|
TOTAL
|
|||||
Philip
R. Chapman
|
$
|
10,000
|
$
|
3,855
|
$
|
13,855
|
||||
Michael
R. Golding
|
10,000
|
3,855
|
13,855
|
|||||||
Gary
L. Herman
|
10,000
|
3,855
|
13,855
|
|||||||
John
F. Hoffner (4)
|
20,000
|
16,150
|
36,150
|
|||||||
Christopher
D. Illick
|
10,000
|
3,855
|
13,855
|
|||||||
Jay
A. Wolf
|
10,000
|
3,855
|
13,855
|
(1)
|
Represents
the annual retainer of $10,000, paid quarterly, along with the fee
for the
chairman of the Audit Committee.
|
(2)
|
Option
awards consist of compensation cost recognized in our financial statements
with respect to awards granted in previous fiscal years and the subject
fiscal year. Option awards are expensed on a straight-line basis
over the
vesting period of the award. The option awards are valued at fair
value
using the Black- Scholes option pricing model. Effective January
1, 2006,
we adopted the fair value based method of accounting
for stock-based employee compensation as required by SFAS No. 123R,
“Share-Based Payment.”
The fair value based method requires us to expense all stock-based
employee compensation. See Note 1 and Note 14 to our audited financial
statements for the 2006 fiscal year, contained in Part I Item 8 “Financial
Statements”, to our Annual Report on Form 10-K for the year ended December
31, 2006, for the methodology used and assumptions made in the valuation
of our options.
|
(3)
|
We
granted options to purchase an aggregate of 150,000 shares of our
common
stock to non-employee directors in 2006. Options to purchase an aggregate
of 480,000 shares of our common stock were outstanding at the fiscal
year
end to non-employee directors.
|
(4)
|
Mr.
Hoffner resigned from the Board of Directors and as Chair of the
Audit
Committee effective as of January 1,
2007.
|
Audit
Committee,
Christopher
D. Illick, Chairman
Michael
R. Golding
|
FISCAL
YEAR
|
|||||||
CATEGORY
|
2006
|
2005
|
|||||
Audit
Fees
|
$
|
93,800
|
$
|
63,500
|
|||
Audit-Related
Fees
|
-
|
-
|
|||||
Tax
Fees
|
16,000
|
17,000
|
|||||
All
Other Fees
|
2,425
|
62,608
|
|||||
Total
Fees
|
$
|
112,225
|
$
|
143,108
|
By
Order of the Board of Directors
Warren
R. Nelson
Secretary
|
o
FOR
|
o WITHHOLD
AUTHORITY
|
all
listed nominees (except do not vote
|
|
for
the nominee(s) whose name(s)
|
|
appear(s)
below):
|
Dated:_______________________,
2007
|
|
(Signature) | |
(Signature if held jointly) | |
The
above-signed acknowledges receipt of the Notice of
Annual
Meeting of Stockholders and the Proxy Statement
furnished
therewith.
|
|
•
|
the
integrity of the Company’s financial statements and financial reporting
process;
|
•
|
the
Company’s systems of internal
controls;
|
•
|
the
performance of the Company’s accounting function and independent auditors;
and
|
•
|
the
independent auditor’s qualifications and
independence.
|
•
|
Size
of Committee
|
The
Committee shall consist of at least two independent
directors.
|
•
|
Member
Qualifications
|
The
members of the Committee shall meet the independence and experience
requirement of applicable federal securities laws, including, the
rules
and regulations of the Commission. Each member of the Committee
must be
able to read and understand fundamental financial statements, including
a
balance sheet, income statement
|
and
cash flow statement. In addition, at least one member should be
an “audit
committee financial expert” as determined by the Board in accordance with
the rules of the Commission.
|
•
|
Appointment
to Committee
|
The
members of the Committee shall be appointed by the Board upon the
recommendation of the Nominating Committee. The Board shall make
the
appointments to the Committee at the organization meeting following
each
Annual Meeting of Stockholders.
|
•
|
Term
|
Members
will be appointed by the Board for a one year term or until a successor
is
appointed and qualified. The
full Board will fill vacancies on the Committee and may remove
a Committee
member from membership on the Committee at any time without
cause.
|
•
|
Committee
Chair
|
The
Committee Chair will be a board member appointed by the Board.
If the
Committee Chair is absent from a meeting, another member of the
Committee
will act as Chair.
|
•
|
Annual
Review of Committee and Charter
|
The
Committee shall annually review the Committee’s own performance, which
shall include eliciting input from management and the independent
auditor
on the performance of the Committee. The Committee shall report
the
results of such self-assessment to the
Board.
|
Not
less than annually, the Committee shall review this Charter and
recommend
to the Board any changes it deems advisable. Only the full Board
of
Directors may amend this Committee’s
Charter.
|
•
|
Compensation
|
Members
of the Committee shall, at the discretion of the Board, be entitled
to
receive fees for service on the Committee or for service as Chair
of the
Committee, in addition to the normal fees paid to all
directors.
|
1.
|
Have
the sole authority and responsibility for the appointment, retention,
oversight, termination and replacement of the independent auditor
(subject, if applicable, to shareholder ratification). The Committee
shall
be directly responsible for the compensation and oversight of the
work of
the independent auditor for the purpose of preparing and issuing
an audit
report and related work.
|
No
audit services or non-audit services shall be performed by the
independent
auditor for the Company unless the services and related costs are
first
pre-approved by the Committee and unless permitted by the rules
and
regulations of the Commission. If the Committee approves an audit
service
within the scope of the engagement of the independent auditor,
such audit
services shall be deemed to have been pre-approved for the purposes
of
this Section.
|
2.
|
Perform
the following:
|
a.
|
Obtain
from the independent auditors on an annual basis, the written disclosures
required under Independence Standards Board Standard No. 1 regarding
any
relationships between the auditors and the Company, or any other
relationships that reasonably may be thought to bear on the auditors’
independence;
|
b.
|
Discuss
with the independent auditor the auditor’s independence, including all
relationships between the independent auditor and the Company that
may
impact the independent auditor’s objectivity and
independence;
|
c.
|
Obtain
from the independent auditors on an annual basis, a written statement
that
the Company’s chief executive officer, chief financial officer, controller
or any person serving in an equivalent position to any of the foregoing
for the Company, was not employed by the independent auditor and
did not
participate in any capacity in the audit of the Company during
the one
year period preceding the date of the initiation of the audit for
which
the independent auditor is engaged;
|
d.
|
Recommend
to the Board appropriate action in response to the independent
auditor’s
report to satisfy itself of the independent auditor’s
independence;
|
e.
Review and evaluate the lead audit partner of the independent auditor’s
team;
|
f.
|
Annually
obtain and review from the independent auditor a written report
describing
(i) the independent auditor’s internal quality-control procedures and (ii)
any material issues raised by the independent auditor’s most recent
internal quality-control review or peer review;
and
|
g.
|
Annually
obtain from the independent auditor a written report in which the
independent auditor attests to and reports on the assessment of
the
Company’s internal controls made by the Company’s
management.
|
3.
|
Meet
with the independent auditors and financial management of the Company to
review the scope of the proposed audit for the current year and
the audit
procedures to be utilized.
|
4.
|
Review
each opinion or report of the independent auditors and review any
comments
or recommendations of the independent auditors with respect to
the audited
or interim financial statements.
|
5.
|
Provide
sufficient opportunity for the independent auditors to meet with
the
members of the Committee without members of management present.
Among the
items to be discussed in these meetings are the independent auditors’
evaluation of the Company’s financial and accounting personnel, and the
cooperation that the independent auditors received during the course
of
the audit.
|
Financial
Reporting Process
|
6.
|
Review
significant accounting and reporting issues, including recent professional
and regulatory announcements, and the impact on the financial statements,
including any significant changes in the Company’s selection or
application of accounting principles, any major issues as to the
adequacy
of the Company’s internal controls and any special steps adopted in light
of material control deficiencies.
|
7.
|
Evaluate
whether management is setting the appropriate tone at the top by
communicating the importance of strong internal controls. Obtain
an
understanding of internal controls and the significant risk areas
for the
Company through discussions with management, and the independent
auditors.
Periodically review the adequacy of internal controls that could
significantly affect the Company’s financial statements through
discussions with management and the independent
auditors.
|
8.
|
Review
and discuss with the independent auditor the following as it relates
to
periodic filings with the
Commission:
|
a.
|
all
critical accounting policies and practices used by the
Company;
|
b.
|
all
alternative treatments of the Company’s financial information within GAAP
that have been discussed with management, and the ramifications
of the use
of such alternative treatments and related disclosures;
and
|
c.
|
all
other material written communications between the independent auditor
and
management, such as any management letter or schedule of adjusted
differences.
|
9.
|
Review
with appropriate representatives of management and the independent
auditors the financial information contained in the company’s Quarterly
reports on Form 10-Q prior to filing, the Company’s earnings announcements
prior to release, and the results of the independent auditors’ review of
Interim Financial information pursuant to Statement of Auditing
Standards
Statement No. 71, as may be modified or supplemented. The chairman
of the
Committee may represent the entire Committee, either in person
or by
telephone conference call, for purposes of this
review.
|
10.
|
Review
with appropriate representatives of management and the independent
auditors the scope and timing of the annual audit, as well as the
results
of the audit work performed at the completion of the annual audit
of the
Company’s consolidated financial statements included in the Annual Report
on Form 10-K for the last fiscal year. Prior to its filing, the
Committee
shall, without limitation:
|
a.
|
Review
and discuss the Company’s annual consolidated financial statements and
related footnotes;
|
b.
|
Review
and discuss the independent auditors’ audit of the consolidated financial
statements and their report;
|
c.
|
Review
and discuss any significant changes required in the independent
auditors’
examination plan;
|
d.
|
Discuss
with management and the independent auditor any problems, difficulties
or
disputes encountered during the course of the audit, including
any
restrictions on the scope of the independent auditor’s activities or on
access to requested information, any accounting adjustments that
were
noted or proposed by the independent auditor but that were not
adopted,
any communications between the independent auditor’s team assigned to the
Company’s audit and the auditors affiliated national office, and any
“management” or “internal control” letter issued, or proposed to be
issued, by the independent auditor to the
Company;
|
e.
|
Review
and discuss other matters related to the conduct of the audit which
are to
be communicated to the Committee under general accepted auditing
standards
including, discussions relating to the independent auditors’ judgments
about such matters as the quality, not just the acceptability,
of the
Company’s accounting practices and other items set forth in Statement of
Auditing Standards Statement No. 61 (“SAS61”) (Communication with Audit
Committees) or other such auditing standards that may in time modify,
supplement or replace SAS61; and
|
f. |
Recommend
to the Board of Directors, based on the review and discussions
referred to
above, that the Company’s consolidated financial statements be included in
the Annual Report on Form 10-K for the last fiscal year for filing
with
the Commission.
|
11.
|
Discuss
with management the Company’s earnings press releases, including the use
of “pro forma” or “adjusted” non - GAAP information, as well as financial
information and earnings guidance provided to analysts and rating
agencies, if applicable. Such discussion may be done generally,
consisting
of discussing the types of information to be disclosed and the
types of
presentations to be made.
|
12.
|
Periodically
inquire of management and the independent auditor as to any disagreements
that may have occurred between them relating to the Company’s financial
statements or disclosures. The Committee shall have the sole
responsibility for the resolution of any disagreements between
management
and the independent auditor regarding financial
reporting.
|
13.
|
Review
the activities, organizational structure, and qualifications of
accounting
and financial human resources within the
Company.
|
14.
|
Review
the procedures established by the Company that monitor the compliance
by
the Company with the covenants and restrictions contained in its
loan
agreements.
|
15.
|
Review
with the Company’s counsel any legal matter that could have a significant
impact on the Company’s financial
statements.
|
16.
|
Report
through the Committee Chair to the Board of Directors following
the
meetings of the Committee.
|
17.
|
Maintain
minutes or other records of meetings and activities of the Committee,
all
of which shall be submitted to the Corporate secretary to be filed
with
the minutes of meetings of the Company’s Board of
Directors.
|
18.
|
Review
the Company’s policies and procedures for compliance with laws and
regulations that may impact financial reporting and
disclosure.
|
19.
|
Periodically
review and approve the Company’s ethics code or “Code of Conduct”.
Recommend material changes for approval by the Board of Directors.
Provide
for and review prompt disclosure to the public of any substantive
change
in, or any waiver of, such ethics
code.
|
20.
|
Periodically
review and approve the Company’s procedures for (i) the receipt, retention
investigation and resolution of complaints received by the Company
regarding accounting, internal accounting controls or auditing
matters,
and (ii) the confidential, anonymous submission by employees, in
accordance with the Company’s Whistle Blower’s policy, of concerns
regarding questionable accounting or auditing matters. Monitor
compliance with such
procedures.
|
21.
|
As
requested by the Board, review and investigate conduct alleged
by the
Board to be in violation of the Ethics Code and adopt as necessary
remedial, disciplinary or other measures with respect to such
conduct.
|
22.
|
Conduct
or authorize and investigation of any matter brought to its attention
within the scope of its duties, with the power to retain outside
counsel
for this purpose if, in its judgment, that is appropriate. Report
to the
Board of Directors the results of its investigation and make such
recommendations, as it may deem
appropriate.
|
23.
|
Review
and reassess the adequacy of this Charter annually and recommend
any
proposed changes to the Board for
approval.
|
24.
|
Annually
review its own performance.
|
25.
|
Consider
such other matters in relation to the financial affairs of the
Company,
and in relation to the external audit of the Company as the Committee
may,
in its discretion, determine to be
advisable.
|
26.
|
Perform
any other activities consistent with this Charter, the Company’s By-laws
and charter documents and governing law as the Committee or the
Board of
Directors deems necessary or
appropriate.
|
27.
|
Annually
review the Company’s plans and programs with respect to major areas of
risk management and related insurance
overage.
|
28.
|
Annually
review and monitor the Company’s risk assessment programs and related risk
management strategies.
|
29.
|
Annually
review the Company’s programs on loss prevention and security
matters.
|
30.
|
Review
and approve, on an ongoing basis, all related party
transactions.
|
As
|
|||||
Q1
|
Q2
|
Q3
|
Q4
|
Needed
|
|
External
Auditors
|
|||||
|
|||||
Appointment
of external auditors
|
X
|
||||
Approval
of engagement letter
|
X
|
||||
Review
cost of audit and non-audit services, if any
|
X
|
X
|
X
|
X
|
|
Pre-approval
of non-audit services performed by external
firm
|
X
|
X
|
X
|
X
|
|
External
auditors’ independence
|
X
|
||||
External
auditors’ audit plan, including timing, scope
and procedures
|
X
|
||||
Significant
changes to audit plan, scope restrictions, lack
of info
|
X
|
||||
Local
office’s communication with national office
|
X
|
||||
Disagreements
with management
|
X
|
||||
External
auditors’ report
|
X
|
||||
External
auditors’ management letter
|
X
|
X
|
|||
External
auditors’ opinion of quality of Shells financial
reporting
|
X
|
X
|
X
|
X
|
|
Attestation
report on internal controls
|
X
|
||||
External
auditors’ internal control findings
|
X
|
||||
Significant
accounting and reporting issues
|
X
|
X
|
X
|
X
|
|
External
auditors’ results of Quarterly Review
|
X
|
X
|
X
|
X
|
|
Private
session with external auditors
|
X
|
X
|
X
|
X
|
|
Other
Committee Activities
|
|
||||
Approve
previous meeting minutes
|
X
|
X
|
X
|
X
|
|
File
meeting minutes with Secretary
|
X
|
X
|
X
|
X
|
|
Report
to Board of Directors
|
X
|
X
|
X
|
X
|
|
Report
to shareholders
|
X
|
|
|||
Annual
Self-evaluation
|
X
|
||||
Evaluate
lead audit partner
|
X
|
X
|
|||
Evaluate
management’s role and success in maintaining
internal controls
|
X
|
||||
Management
to discuss with Audit Committee
|
X
|
X
|
X
|
X
|
|
Whistle
Blower reports submitted to management, if
any, and appropriate resolution.
|
|||||
Respond
to and investigate any Whistle Blower reports
submitted to Audit Committee Chairperson.
|
X
|
As
|
|||||
Q1
|
Q2
|
Q3
|
Q4
|
Needed
|
|
Financial
and Related Reporting
|
|||||
Review
of draft Form 10-Q / quarterly public filing
|
X
|
X
|
X
|
||
Review
of draft Form 10-K / annual public filing
|
X
|
||||
Review
of proxy materials and narrative reporting
|
X
|
||||
Review
of Audit Committee Charter (included in proxy)
|
X
|
|
|||
Review
final draft of earnings announcements
|
X
|
X
|
X
|
X
|
|
Review
and discuss critical accounting policies and practices,
alternative treatments, and material communications
between external audit and management
|
X
|
X
|
X
|
X
|
|
Planned
changes in accounting principals
|
|
X
|
|||
Significant
accounting judgment and estimates
|
X
|
X
|
X
|
X
|
|
Discuss
with management the Company’s earnings press
releases
|
|
|
X
|
||
Controls
and Compliance
|
|||||
Evaluation
of disclosure controls
|
X
|
X
|
X
|
X
|
|
Management’s
assessment of internal controls
|
X
|
X
|
X
|
X
|
|
Significant
changes in financial reporting internal controls
|
X
|
X
|
X
|
X
|
|
Status
of Sarbanes-Oxley Section 404 Compliance
|
X
|
X
|
X
|
X
|
|
Project
|
|
||||
Review
accounting and finance organization structure
and qualifications
|
X
|
||||
Monitoring
process for compliance with loan agreements
|
X
|
||||
Review
risk management and related insurance coverage
|
X
|
||||
Review
risk assessment program and risk management
strategies
|
X
|
||||
Review
related party transactions
|
X
|
||||
Review
of independence, experience, and qualifications
of Audit Committee Members
|
X
|
||||
Annual
update on Loss Prevention and Security
|
X
|
||||
Matters
|
|||||
Tax
matters
|
X
|
X
|
X
|
X
|
|
Significant
legal matters
|
X
|
||||
Report
of Charitable Contributions
|
X
|